Volume 8 Issue 119
Published - 14:00 UTC 08:00 EST 29-Apr-2006 
Next Update - 14:00 UTC 08:00 EST 30-Apr-2006

Editor: Susan K. Boyer, RN
Vidyya.
All rights reserved.

HONcode accreditation seal. We subscribe to the HONcode principles.
Verify here
.

  

 


NCI releases report on cancer incidence in Middle East

The National Cancer Institute (NCI), part of the National Institutes of Health, today released Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel and Jordan) of the Middle East Cancer Consortium (MECC) Compared with U.S. SEER. The monograph compiles information on cancer incidence between 1996 and 2001, drawn from cancer registries in four member countries as part of the Joint Cancer Registration Project of the Middle East Cancer Consortium (MECC). more  

Arthritis drug might reduce fatigue in cancer patients

Researchers here have found evidence that combining a drug typically used to treat rheumatoid arthritis with chemotherapy might help reduce fatigue and muscle wasting that often afflicts cancer patients. more

Genetic finding suggests alternative treatment strategy for common, complex skin disorders and asthma

A genetic finding by researchers at the National Institutes of Health provides new insight into the cause of a series of related, common and complex illnesses including hay fever and asthma as well as the skin disorders eczema and psoriasis and suggests a novel therapeutic approach. These illnesses are essentially inflammatory disorders of the tissues that separate the inside of the body from the outside world, such as the skin and the linings of the throat and lungs. more  

History of gestational diabetes raises lifelong diabetes risk in mother and child lifestyle changes can prevent or delay later diabetes

Its Never Too Early to Prevent Diabetes, the latest diabetes prevention campaign message by the National Diabetes Education Program (NDEP), is spreading the word about the risk for type 2 diabetes faced by women with a history of gestational diabetes mellitus (GDM) and their offspring. On April 25th the NDEP joined Deputy Surgeon General, RADM Kenneth P. Moritsugu and Griffin P. Rodgers, M.D., acting director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), one of the National Institutes of Health (NIH), in Washington to announce this latest message in an ongoing national public awareness effort. The NDEP is jointly sponsored by the NIH and the Centers for Disease Control and Prevention, agencies of the U.S. Department of Health and Human Services. more

Steroids do not prolong survival in intensive care patients with ards on life support, finds NHLBI study 

Corticosteroids do not improve survival in patients with late-stage acute respiratory distress syndrome (ARDS), according to new results from the ARDS Clinical Research Network of the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. The study is the first multi-center randomized clinical trial to evaluate the effects of moderate doses of steroids in ARDS patients when treatment is started 7 days or more after the onset of the condition. more

Almost 1/3 of colon cancer patients stop chemotherapy, leading to double the death rate  

New research from Columbia University Medical Center has found that as many as 30 percent of patients with stage III colon cancer who were prescribed six months of chemotherapy with a combination of 5-fluorouracil and leucovorin stopped their treatment prematurely. Stopping chemotherapy for colon cancer prematurely was shown to be equivalent to receiving no treatment at all. The findings add to the arsenal of reasons why colon cancer patients, and all cancer patients, need to complete their chemotherapy regimens whenever possible. more

Choice of chemotherapy before liver metastasis surgery matters for some patients

Patients and their physicians should be careful when selecting a chemotherapy drug to treat colorectal cancer that has spread to the liver, say researchers at The University of Texas M. D. Anderson Cancer Center in Houston. more

 

The National Cancer Institute (NCI), part of the National Institutes of Health, released Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel and Jordan) of the Middle East Cancer Consortium (MECC) Compared with U.S. SEER.